Table 4.
List of leading coronavirus vaccines at the early approval for COVID-19.
| Vaccine Name/Developer | Type | Phase (Clinical Trials) | Recent European and National (UK) Approval |
|---|---|---|---|
| Pfizer-BioNTech | mRNA | 3 | Emergency use in the U.S., E.U., and other countries. Approved in several countries. |
| Moderna | mRNA | 3 | Approved in Switzerland. Emergency use in the U.S., U.K., E.U., others. |
| Oxford-AstraZeneca | Adenovirus | 3 | Emergency use in the U.K., E.U., others. Approved in Brazil |
| Gamaleya | Adenovirus (Ad26, Ad5) | 3 | Emergency use in Russia, other countries. |
| CanSino | Adenovirus (Ad5) | 3 | Approved in China, emergency use in other countries. |
| Johnson &Johnson | Adenovirus (Ad26) | 3 | Emergency use in U.S., E.U., others. |
| Vector Institute | Protein | 3 | Approved in Turkmenistan. Early use in Russia. |
| Novavax | Protein | 3 | |
| Sinopharm | Inactivated | 3 | Approved in China, U.A.E., Bahrain. Emergency use in other countries. |
| Sinovac | Inactivated | 3 | Approved in China. Emergency use in other countries. |
| Sinopharm-Wuhan | Inactivated | 3 | Approved in China, limited use in U.A.E. |
| Bharat Biotech | Inactivated | Emergency use in India, other countries |